US FDA approves Amgen’s Uplizna as first treatment for rare immune disorder
By Deena Beasley, Mariam Sunny and Siddhi Mahatole (Reuters) -The U.S. Food and Drug Administration has approved expanded use of...
By Deena Beasley, Mariam Sunny and Siddhi Mahatole (Reuters) -The U.S. Food and Drug Administration has approved expanded use of...
By Olesya Astakhova, Ahmad Ghaddar and Alex Lawler LONDON/MOSCOW (Reuters) -Eight OPEC+ countries agreed on Thursday to advance their plan...
By Mike Dolan LONDON (Reuters) - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Financial Industry...
COPENHAGEN (Reuters) - Shipping company Maersk said on Thursday that the tariffs announced by U.S. President Donald Trump on Wednesday...
By Nicole Jao (Reuters) - Oil prices dropped $2 on Thursday after U.S. President Donald Trump announced reciprocal tariffs on...
Tejas Vijh moved to the US in 2022 to grow his career in venture capital.Tejas Vijh Tejas Vijh navigated visa...
WASHINGTON (Reuters) - Imports of oil, gas and refined products were exempted from U.S. President Donald Trump’s sweeping new tariffs,...
(Bloomberg) -- Artificial intelligence coding startup Replit Inc. is in talks with investors for a new funding round that would...
By David Shepardson WASHINGTON (Reuters) - Boeing is in discussions with the U.S. Department of Justice to reach a revised...
By Amanda Stephenson CALGARY (Reuters) - Canada's Trans Mountain oil pipeline has downgraded forecasts for the amount of oil expected...
TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.
© 2024 Todayheadline.co